ÂÜÀòÂÒÂ×

Dr Arunraj Patil, PhD. LL.B. has had a long and varied career in the pharmaceutical industry. In 2000, they began working as the API Head (VP Tech. Operations) for S.M Biomed Sdn Bhd in Malaysia, where they were responsible for the profitability of the company. In 2008, they moved to Teva Pharmaceuticals, where they were the Vice President Operations & Site Head. Dr Arunraj then moved to Apotex Pharmchem Inc. in Canada in 2011, where they were the Corporate - Global Mfg Operations. In 2014, they were appointed CEO of Global Pharma Business at Supriya Lifescience Limited. From 2017 to 2020, they worked at Cadila Pharmaceuticals Limited as President & Strategic Business Head API, where they were responsible for the P & L of the Strategic Business Unit (API Division). Since 2020, they have been the Chief Business Officer - API and President - Global Pharma Business (Sales, Marketing & BD) at Modavar Pharmaceuticals LLC, where they are seeking to secure the present and prepare for tomorrow by collaborating with their strategic partnership program.

Dr Arunraj Patil completed their Msc PhD. LLB in Medicinal Organic Chemistry from the University of Mumbai between 1983 and 1988. Dr Arunraj then attended the Indian Institute of Management Ahmedabad in 2019, where they completed a Strategic Leadership Development Organizational Programe.